RxDoctor Payments Data

Kristen Bolton

Physician Assistant · Fort Worth, TXNPI 1275641342

Payments from drug & device makers

$3,871in general payments, 2019–2025

Across 207 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$604
  • AbbVie$563
  • Boehringer Ingelheim$338
  • Lilly USA, LLC$317
  • AstraZeneca$313
  • Echosens North America, Inc.$309
  • plus $1K from 29 others

What the payments were for

  • Food & beverage$3,871100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,871 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide43$50,497
OzempicSemaglutide11$11,899
JardianceEmpagliflozin12$9,101
MyrbetriqMirabegron11$8,852
Duloxetine Hcl28$571
Levothyroxine Sodium40$423
Atorvastatin Calcium63$395
Hydroxyzine Hcl19$303
Gabapentin23$281
Metformin Hcl34$250
Montelukast Sodium22$240
Amlodipine Besylate42$214
Olmesartan Medoxomil17$212
Meloxicam17$204
Omeprazole13$189

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$317$50,49743 claims
Novo NordiskOzempic$604$11,89911 claims
Boehringer IngelheimJardiance$338$9,10112 claims
Astellas Pharma US IncMyrbetriq$270$8,85211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →